| Authors: |
Thiel KW; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA., Devor EJ; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA., Filiaci VL; NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Mutch D; Washington University School of Medicine, Siteman Cancer Center, St Louis, MO., Moxley K; Stephenson Cancer Center, Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City, OK., Alvarez Secord A; Duke University Institute, Duke University Health System, Durham, NC., Tewari KS; University of California Irvine Medical Center, Irvine, CA., McDonald ME; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA., Mathews C; Women and Infants Hospital in Rhode Island/The Warren Alpert Medical School of Brown University, Providence, RI., Cosgrove C; Ohio State University Medical Center, James Cancer Hospital and Solove Research Institute, Obstetrics and Gynecology, Columbus, OH., Dewdney S; Rush University Medical Center, Gynecology, Chicago, IL., Aghajanian C; Memorial Sloan Kettering Cancer and Weill Cornell Medical Center, New York, NY., Samuelson MI; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA., Lankes HA; Biopathology Center, The Research Institute at Nationwide Children's Hospital, Columbus, OH., Soslow RA; The University of New Mexico Health Sciences Center, Albuquerque, NM., Leslie KK; Department of Obstetrics and Gynecology, University of Iowa, Iowa City, IA.; The University of New Mexico Health Sciences Center, Albuquerque, NM. |